📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting. (2020)

First Author: Hanekamp D

Attributed to: Clinical Investigation of a Humanized Anti-CD47 Antibody in Targeting Cancer Stem Cells in Acute Myelodi Leukaemia (and Solid Tumours). funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.16594

PubMed Identifier: 32239670

Publication URI: http://europepmc.org/abstract/MED/32239670

Type: Journal Article/Review

Volume: 190

Parent Publication: British journal of haematology

Issue: 6

ISSN: 0007-1048